CU20120167A7 - NEW ASSOCIATION BETWEEN 4- {3- (CIS-HEXAHYDROCICLOPENTA (C) PIRROL-2 (1H) -IL) PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT - Google Patents

NEW ASSOCIATION BETWEEN 4- {3- (CIS-HEXAHYDROCICLOPENTA (C) PIRROL-2 (1H) -IL) PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Info

Publication number
CU20120167A7
CU20120167A7 CU20120167A CU20120167A CU20120167A7 CU 20120167 A7 CU20120167 A7 CU 20120167A7 CU 20120167 A CU20120167 A CU 20120167A CU 20120167 A CU20120167 A CU 20120167A CU 20120167 A7 CU20120167 A7 CU 20120167A7
Authority
CU
Cuba
Prior art keywords
antagonist
cis
hexahydrociclopenta
propoxi
benzamida
Prior art date
Application number
CU20120167A
Other languages
Spanish (es)
Inventor
Aurore Sors
Caryn Trocme-Thibierge
Annette Merdes
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of CU20120167A7 publication Critical patent/CU20120167A7/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Asociación entre la 4-{3-[cis-hexahidrociclopenta[c]pirrol-2(1H)-il]propoxi}benzamida de fórmula(I): o una de sus sales de adición a un ácido o a una base farmacéuticamente aceptable, y un antagonista de los receptores glutamatérgicos NMDA.Association between 4- {3- [cis-hexahydrocyclopenta [c] pyrrol-2 (1H) -yl] propoxy} benzamide of formula (I): or one of its addition salts to a pharmaceutically acceptable acid or base, and an antagonist of the NMDA glutamatergic receptors.

CU20120167A 2011-12-09 2012-12-06 NEW ASSOCIATION BETWEEN 4- {3- (CIS-HEXAHYDROCICLOPENTA (C) PIRROL-2 (1H) -IL) PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT CU20120167A7 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161568831P 2011-12-09 2011-12-09

Publications (1)

Publication Number Publication Date
CU20120167A7 true CU20120167A7 (en) 2014-10-30

Family

ID=52392468

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20120167A CU20120167A7 (en) 2011-12-09 2012-12-06 NEW ASSOCIATION BETWEEN 4- {3- (CIS-HEXAHYDROCICLOPENTA (C) PIRROL-2 (1H) -IL) PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT

Country Status (1)

Country Link
CU (1) CU20120167A7 (en)

Similar Documents

Publication Publication Date Title
CY1123365T1 (en) COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENORECTOR AGENT ACTIVITY
CY1118379T1 (en) DISEASES OF USVITIS C
CU20120064A7 (en) NEW ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCICLOPENTA [C] PIRROL-2 (1H) -IL] PROPOXI} BENZAMIDA AND AN INHIBITOR OF ACETILCOLINESTERASE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING IT
EA201591008A1 (en) Pyridine-2-amides, suitable as agonists of cannabinoid receptor 2
CR20140332A (en) BROMODOMINIUM INHIBITORS
EA201492281A1 (en) N-Aryltriazole Compounds As Antagonists Of Lyophasophatic Acid Receptors (LPAR) Antagonists
UA112317C2 (en) 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
MX2015008233A (en) Novel quinolone derivatives.
EA201490471A1 (en) PYRIDAZINOUS COMPOUNDS AND THEIR APPLICATION AS DAAO INHIBITORS
UA111640C2 (en) DERIVATIVES [1,2,3] TRIAZOLO [4,5-d] PYRIMIDINE AS A cannabinoid receptor agonist 2
NI201400134A (en) NOVELTY N - PYRIDINIL CYCLIC AMIDES REPLACED AS KINASE INHIBITORS.
EA201500628A1 (en) INDOLKARBOXAMID DERIVATIVES AS ANTAGONISTS OF P2XRECEPTORS
EA201370149A1 (en) ANTAGONISTS RECEPTOR
CR20140516A (en) PIRAZOL COMPOUNDS REPLACED AS AN LPG ANTAGONIST
EA201300857A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
ECSP12012329A (en) NEW ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCICLOPENTA [C] PIRROL-2 (1H) -IL] PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
NI201200102A (en) PROCEDURE FOR THE SYNTHESIS AND CRYSTALLINE FORM OF THE HYDROCHLORIDE OF 4 - {3 - [CIS - HEXAHYDROCYCLOPENTA [C] PYRROL - 2 (1H) - IL] PROPOXI} BENZAMIDE AS WELL AS THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
EA201301136A2 (en) NEW METHOD OF SYNTHESIS (2E) -3- (3,4-DIMETOXYPHENYL) PROP-2-ENNITRIL, APPLICATION IN IVABRADINE AND ITS PHARMACEUTICAL ACCEPTIVE SALTS
CY1115682T1 (en) NEW METHOD OF COMPOSITION OF IVABRADIN AND ITS ADDITIVES WITH A PHARMACEUTICAL ACCEPTABLE ACID
CU20120167A7 (en) NEW ASSOCIATION BETWEEN 4- {3- (CIS-HEXAHYDROCICLOPENTA (C) PIRROL-2 (1H) -IL) PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
EA201301235A1 (en) A NEW METHOD OF SYNTHESIS OF 3- (2-BROM-4,5-DIMETOXYPHENYL) PROPNANITRIL AND THE APPLICATION OF IVARBRADINE AND ITS PHARMACEUTICALLY ACCEPTABLE ACID-SALTES IN SYNTHESIS
SV2012004361A (en) NEW ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCICLOPENTA [C] PIRROL-2 (1H) -IL] PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
EA201301020A1 (en) A NEW METHOD OF SYNTHESIS OF 3- (2-BROM-4,5-DIMETOXYPHENYL) PROPNANITRIL AND THE APPLICATION OF IVARBRADINE AND ITS PHARMACEUTICALLY ACCEPTABLE ACID-SALTES IN SYNTHESIS
CY1117356T1 (en) NEW METHOD OF COMPOSITION OF IVABRADIN AND ITS ADDITIVES WITH A PHARMACEUTICAL ACCEPTED ACID
AR087490A1 (en) SOLID PHARMACEUTICAL COMPOSITION FOR AGOMELATINE ORAL ADMINISTRATION